Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.

Mazhindu TA, Nagy M, Twesigomwe D, Agesa G, Scholefield J, Masimirembwa C

Open source

DOI
10.1002/cpt.70268
Published
2026 May
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70268,
  title = {Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.},
  author = {Mazhindu TA and Nagy M and Twesigomwe D and Agesa G and Scholefield J and Masimirembwa C},
  year = {2026},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.70268},
  url = {https://doi.org/10.1002/cpt.70268}
}

RIS

TY  - JOUR
TI  - Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.
AU  - Mazhindu TA
AU  - Nagy M
AU  - Twesigomwe D
AU  - Agesa G
AU  - Scholefield J
AU  - Masimirembwa C
PY  - 2026
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.70268
UR  - https://doi.org/10.1002/cpt.70268
ER  - 

APA

TA, M., M, N., D, T., G, A., J, S., & C, M. (2026). Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70268

Source records